Early evaluation of circulating tumor DNA as marker of therapeutic efficacy in metastatic colorectal cancer patients (PLACOL study)

F Garlan, P Laurent-Puig, D Sefrioui, N Siauve… - Clinical Cancer …, 2017 - AACR
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are
essential for optimization of treatment strategies. We evaluated the applicability of early …
被引用次数：229 相关文章

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

F Garlan, P Laurent-Puig, D Sefrioui, N Siauve… - Clinical Cancer …, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Markers of chemotherapy efficacy in
metastatic colorectal cancer (mCRC) are essential for optimization of treatment strategies …

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

F Garlan, P Laurent-Puig, D Sefrioui… - … : an official journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are
essential for optimization of treatment strategies. We evaluated the applicability of early …

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

F Garlan, P Laurent-Puig, D Sefrioui, N Siauve… - Clinical Cancer …, 2017 - hal.science
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are
essential for optimization of treatment strategies. We evaluated the applicability of early …

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

F Garlan, P Laurent-Puig, D Sefrioui… - Clinical Cancer …, 2017 - inserm.hal.science
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are
essential for optimization of treatment strategies. We evaluated the applicability of early …

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study).

F Garlan, P Laurent-Puig, D Sefrioui… - … Cancer Research: an …, 2017 - europepmc.org
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are
essential for optimization of treatment strategies. We evaluated the applicability of early …